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structure of this substance is reported to be 5-formyl-5 : 6 : 7: 8-tetrahydropteroylglutamic acid. We do not know much about conjugate forms of folinic acid but, as will be explained later, it is likely that in certain tissues and organs the activity that has been attributed to folic acid or its conjugates is due at least in part to folinic acid or its conjugates.
Microbiological interrelationships and quantitative estimation of these haemopoietic factors Under suitable assay conditions, vitamin B,, is a growth factor for Lactobacillus leichmannii, Lb. lactis Dorner, Euglena gracilis and Bacterium coli.
I shall not consider further the difficulties involved in carrying out the assays, as this is dealt with by Ford (1952) .
Pteroylglutamic acid is usually estimated by its growth-promoting effect upon
Streptococcus faecalis R or Lb. casei. Pteroyldiglutamic acid will not support the growth of either of these organisms, whereas pteroyltriglutamic acid supports the growth of Lb. casei but not that of Strep. faecalis unless present in high concentration. Thymine and thymidine (thymine deoxyriboside) can replace pteroylglutamic acid for the growth of Lb. casei and Strep. faecalis. The citrovorum factor is measured quantitatively by virtue of its growth-promoting effect upon L a c . citrovorum. However, it will also support the growth of Lb. casei and Strep. ,faecalis and the true folic-acid content of substances being tested is arrived at by a differential assay method, using both Lb. citrovorum and Strep. faecalis as test organisms (Swendseid, Bethel1 & Ackermann, 1951) . Under the conditions of my own differential assays, citrovorum factor has about 76 yo of the growth-promoting effect of pteroylglutamic acid for Strep. faecalis.
Thymidine can diminish the requirements of Leuc. citrovorum for folinic acid, but folic acid is inactive for Leuc. citrovorum unless present in very high concentration.
Other complications are many, and time does not permit me to mention them.
I have found the folinic-acid assay to be far the most consistent and satisfactory. With the other assays difficulties are very frequent. Stokes (1944) could not demonstrate folic acid in organisms grown in a medium containing thymine in place of folic acid and suggested that folic acid functions as a coenzyme for the enzyme system responsible for the synthesis of thymine, the latter being used by the bacteria to form nucleic acid: Responses to liver injections, vitamin B,,, proteolysed liver, marmite, deoxyribosenucleic acid, ribosenucleic acid, thymine and histidine have been poor (Cartwright, Palmer, Tatting, Ashenbrucker & Wintrobe, 1950). There is one paper describing pigs that appeared to become so depleted of vitamin B,, and folic acid that folic acid failed to give a response until vitamin B,, injections (liver injections) were given and, conversely, liver injections failed unless folic acid was given (Heinle, Welch & Pritchard, 1948) . In general, the experiments indicate the importance of supplying both vitamin B,, and folic acid to prevent megaloblastic anaemia in the pig. Protein deficiency increases the need for folic acid.
In considering megaloblastic anaemia in the monkey, we are faced with the problem of Wills's factor. As is well known, Wills studied nutritional megaloblastic anaemia in man in India, and in monkeys (Wills & Stewart, 1935; Wills, Clutterbuck & Evans, 1937; Wills & Evans, 1938) . Anahaemin (British Drug Houses Ltd.) , which was active in pernicious anaemia, was inactive in nutritional megaloblastic anaemia. Campolon (Bayer Products Ltd.) was active in pernicious anaemia and, when separation with ammonium sulphate was carried out, both the soluble and insoluble fractions were active in this disorder. However, only the soluble fraction was active in nutritional megaloblastic anaemia in man and in the monkey. Strauss & Castle (1932) state that the autolysed yeast preparation, marmite, which does not contain vitamin B,,, is active by mouth in pernicious anaemia only if given with gastric juice. However, marmite was active in nutritional megaloblastic anaemia. The main problem is whether Wills's factor is folic acid, folinic acid, or some other unindentified substance. The monkeys received 5 g of marmite daily (Wills & Stewart, 1935) an amount that is said to contain 0-3 mg of growth factors for Strep. faecalis (as pteroylglutamic acid). However, Day & Totter (1948) have shown that this is more than sufficient to protect the animals against anaemia. The normal daily intake of folic or folinic acid required to prevent nutritional megaloblastic anaemia in man is uncertain ; it is probably less than IOO pglday; the minimal amount required to treat a patient with pernicious anaemia is quite another matter. It is known that the content of folic and folinic acid in present-day liver extracts is very small (usually less than 1-5 pglml.), but what we really would need to know is the content of these factors in Campolon in 1931-7 when Wills was doing her researches, and attempts are being made at present to obtain such material. The action of marmite in Wills's experiments could be explained on its content of growth factors for Strep. faecalh, though why marmite is not more effective in pernicious anaemia or why gastric juice potentiates its action is not fully understood. Perhaps the folic or folinic acid of marmite is present in a conjugate form from which it is released or made available by gastric juice, or perhaps gastric juice neutralizes inhibitors. Full understanding of the significance of separation by ammonium sulphate would appear to necessitate a knowledge of the effect of such separation not only upon folic acid and folinic acid but also upon their conjugates.
To complicate the experiments with monkeys further, it is now known that in the monkey placed on a deficient diet, megaloblastic anaemia develops more rapidly if there is ascorbic-acid deficiency. When it does develop, folic acid is rapidly effective in treatment, ascorbic acid is more slowly effective, vitamin B,, is ineffective, and vitamin B,, together with ascorbic acid gives a prompt response (May, Nelson, Lowe & Salmon, 1950) . In infants, too, megaloblastic anaemia due to folic-acid deficiency occurs more rapidly if there is ascorbic-acid deficiency.
I shall not deal at all with the animal protein factor or with the effects of antibiotics, as these are being discussed separately (Coates, 1952; Cuthbertson, 1952).
Other metabolic interrelationships
It is now clear that folic acid and vitamin B,, take part in many processes concerned with the utilization of proteins not only for haemopoiesis but also for growth and development. For example, it has been shown in chicks that folic acid is involved in the conversion of choline to betaine and in transmethylation from betaine to methionine (Dinning, Keith & Day, 1951) . Vitamin B,, also functions in methionine formation (Oginsky, 1950). Again, glycine toxicity in young chicks can be overcome by vitamin B1, and to a lesser extent by folic acid, but the two together are more effective than either alone (Machlin, Denton & Bird, 1951) . These and other interrelationships could well be the subject of a symposium in themselves.
Bone-marrow cultures
In bone-marrow cultures, Rusznyik, Lowinger & Lajtha (1947) showed that the serum contained a factor that inhibited the conversion of megaloblasts to normoblasts.
Folic acid and folinic acid caused such conversion, whereas vitamin B,, was ineffective except when mixed with a source of intrinsic factor (Callender & Lajtha, 1951).
Lajtha (1950) has suggested that folic acid (or folinic acid) acts directly on the red-cell precursors, but that this activity is inhibited normally by a factor in the serum. This inhibitory factor is counteracted by vitamin B,, after the latter has been converted to an active form in the body. On the other hand, Horrigan, Jarrold & Vilter (I951), Metabolic and therapeutic studies in man At an early stage in the investigations of the action of folic acid in the megaloblastic anaemias, Bethell, Meyers, Andrews, Swendseid, Bird & Brown (1947) suggested that an important function of the liver factor (vitamin B,,) is to liberate folic acid from its conjugates, and that this cannot occur in pernicious anaemia. This conclusion was based upon measurements of urinary excretion of folic acid in pernicious-anaemia patients and controls after the administration of the naturally occurring conjugate, pteroylhexaglutamylglutamic acid. Unfortunately difficulties arose in confirming this work because it was found that the sources of the natural conjugate contained 'conjugase inhibitors' that complicated the experiments without altogether invalidating them. In support of this theory was the fact that all forms of megaloblastic anaemia responded in the first instance to folic-acid therapy. It is now known that in some patients treated for a period of years with folic acid, haematological relapse may occur.
I should like to describe briefly such a patient, part of whose story has already been published (Girdwood, 19pa) .
The patient was a male aged 23 years, suffering from the sprue syndrome with 68 yo absorption of fat; the test meal showed histamine-fast achlorhydria. He had a markedly megaloblastic marrow although he had been taking folic acid by mouth in a dosage of 5 mg daily for more than 2 year$. As will be seen from Fig. I there was then no response to 15 mg folic acid daily intramuscularly, but 90 mg daily converted the marrow to the normoblastic state and led to a rise in the red cells. This improvement was not maintained with 90 mg of folic acid intramuscularly weekly, and the patient was readmitted to hospital in November 1951, with pneumonia. The marrow was again megaloblastic.
The lung infection did not respond well to sulphonamide therapy. I was anxious to try the effect of vitamin B,, on the blood picture of this patient who was not in the ward to which I am attached. Unfortunately on the very day that this treatment was given the doctor who was responsible for attending to the patient was himself taken ill and penicillin was given to the sprue patient without my prior knowledge. This perhaps complicates matters since there have been reports from Africa of responses to penicillin in megaloblastic anaemia, but in any event it can be said that the blood picture was restored rapidly to normal although the haemopoietic tissues had become refractory to very large doses of folic acid.
I imagine that the most likely explanation of this response is that the patient was unable to absorb vitamin B,, and that folic acid could not be effective in its absence. It might be suggested that folinic acid would have been effective and that perhaps the function of vitamin B,, is to play some part in the conversion of folic acid to folinic acid. However, Jarrold, Horrigan, Thompson &Vilter (195 I ) have reported on a patient with pernicious anaemia who became refractory to folic acid. There was no response to Lederle's synthetic preparation of citrovorum factor, but vitamin B,, was effective.
In support of the theory that vitamin B, , releases folic acid from its conjugates, it has been reported (SuPrez, Welch, Heinle, Suirez & Nelson, 1946; Anonymous, 1947 ) that liver-extract injections give rise to increased urinary excretion of folic acid in pernicious anaemia and sprue. As will be seen in Fig. 2 If synthetic folic-acid conjugates are given by mouth or by injection to patients with pernicious anaemia, there is a haemopoietic response and excretion of pteroylglutamic acid. Table I shows the urinary excretion of pteroylglutamic acid in eight patients treated in this way-in only two patients given the dose indicated for several days was there no haemopoietic response. All that this experiment shows, however, is that the pernicious-anaemia patient can convert these particular synthetic forms to ' free ' folic acid. For comparison, the average excretion of folic acid in the urine of eight pernicious-anaemia patients given 5 mg pteroylglutamic acid intramuscularly was 1-05 mg. Finally, I want to refer briefly to a few of the metabolic mysteries of the megaloblastic anaemias. Mollin & Ross (195 I), using Euglenagracilis as test organism, have found that the urinary and serum values for vitamin B,, are lower in pernicious-anaemia patients than in controls. On the other hand, using Lb. leichmannii (and correcting W.
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of folinic acid is much less when it is given by mouth, although it is haemopoietically active by both routes and is not excreted as folk acid. If this is merely a matter of poor absorption by the alimentary route, it is surprising that oral treatment is satisfactory. I n contrast, if folic acid is given in comparable dosage, the urinary output of folic acid is similar whether it be given by injection or by mouth, and only a small proportion (0.1 yo or less) is excreted as the citrovorum factor.
The livers of two non-anaemic control patients examined at autopsy contained 162.3 and 523.7 pg/Ioo g respectively of citrovorum factor, but no folic acid. At autopsy, the liver of a pernicious-anaemia patient who died the day after having been given IOO pg. vitamin B12, contained 78-9 pg citrovorum factor and 61.6 pg folic acid per 100g (Girdwood, 195zb) . This should only be taken as an indication for further investigation along similar lines.
Holly (1951), acting on the suggestion of May el al. (1950) that ascorbic-acid deficiency may interfere with the conversion of folic acid to folinic acid, has treated patients with megaloblastic anaemia of pregnancy with vitamin BIZ and ascorbic acid. In three such patients, vitamin B,, and ascorbic acid separately were ineffective, whereas the two together gave a haematological remission.
These results, if confirmed, suggest that, as in the megaloblastic anaemias of infants and of monkeys, ascorbic-acid deficiency plays a part in the causation of at least some cases of megaloblastic anaemia of pregnancy.
concl ?rsi o?ts
All that we can conclude at present is that vitamin B,, and folic acid both appear to be required for normoblastic blood formation. It is probable that folic acid is normally converted in the body to folinic acid, but this latter substance is not the end of the metabolic chain. There is some indirect evidence for the presence of inhibitory factors (Lajtha, 1950; Ungley, 1951) , but their existence is still problematical. Ascorbic-acid deficiency appears to be related to the development of megaloblastic anaemias, although this form of anaemia is not found in scurvy itself. The existence of other factors is possible. We have seen that Wills's factor has not yet been satisfactorily explained. Moreover, in certain forms of anaemia where the marrow is frequently megaloblastic (e.g. in sprue) there are some cases where the marrow is not truly megaloblastic but contains cells intermediate between megaloblasts and normoblasts. This type of anaemia frequently fails to respond to vitamin B,, or folic acid, possibly because some other unknown factor is lacking.
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